Data / Form D filings / SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc.: Form D filings
SAB Biotherapeutics, Inc., a biotechnology company in Miami Beach, FL, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on August 5, 2025, reports $175 million sold of a $175 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 777 W 41st St, Suite 401, Miami Beach, FL, 33140
- Phone
- (305) 845-2813
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1833214
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | New notice | $175,000,000 | $175,000,000 | 17 | Jul 21, 2025 | sec.gov | |
| Oct 16, 2023 | New notice | $7,500,000 | $7,500,000 | 13 | Oct 2, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Moin | Director | |
| Jay Skyler | Director | |
| Erick Lucera | Director | |
| Samuel Reich | Executive Officer, Director | |
| William Polvino | Director | |
| Katie Ellias | Director | |
| Eddie Sullivan | Executive Officer, Director | |
| Jeffrey Spragens | Director | |
| David Link | Director | |
| Scott Giberson | Director | |
| Christine Hamilton | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SAB Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.